NCT07191496

Brief Summary

To assess the quality of life for women who were pregnant during their breast cancer treatment.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 16, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 24, 2025

Completed
7 days until next milestone

Study Start

First participant enrolled

October 1, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 9, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 9, 2026

Completed
Last Updated

April 17, 2026

Status Verified

April 1, 2026

Enrollment Period

6 months

First QC Date

September 16, 2025

Last Update Submit

April 14, 2026

Conditions

Breast Cancer SurvivorPregnant WomenQuality of Lifte

Outcome Measures

Primary Outcomes (1)

  • QOL Questionnaires

    Through study completion; an average of 1 year

Interventions

QuestionnaireOTHER

The questionnaires include the Ferrans and Powers QLI, EORTC QLQ-C30, FCR-7 Scale, HADS, and MOS Social Support Survey.

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemales
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

MD Anderson Cancer Center

You may not qualify if:

  • Any woman who delayed and received their chemotherapy after delivery.
  • Any woman who was diagnosed with breast cancer before or after their pregnancy.
  • Any woman whom there is documentation of inability to provide consent in the medical record

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

MeSH Terms

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Eileen Hacker, MD

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 16, 2025

First Posted

September 24, 2025

Study Start

October 1, 2025

Primary Completion

April 9, 2026

Study Completion

April 9, 2026

Last Updated

April 17, 2026

Record last verified: 2026-04

Locations

US(1)